🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Are you a bronchiectasis nerd? Want to come live in a city with the best beaches in the world? Look no further. This is your dream job opportunity! North Metropolitan Health Service The Respiratory Health infrastructure will allow you to grow your research too! TSANZ British Thoracic Society (BTS) ERS

And you can work with a world class pleural service! Spread the word for our new CF/Bronchiectasis consultant position please.

Our Charlie’s Respiratory experts stealing the show at the Airways 2024 meeting in Sydney (1/4)

Sanjay Ramakrishnan talking eosinophils in COPD (3/4)

Today is #worldCODPday, started by @gold_copd. This years theme is "Know Your Lung Function" as #spirometry is important for diagnosis & monitoring lung health. TSANZ members worked with ACSQHC to develop the recent clinical standards on COPD. shorturl.at/zAWod

A new era in the treatment of acute exacerbations of #asthma and #COPD - The ABRA Trial. Clarus Leung and I highlight ABRA's importance as well as its limitations. thelancet.com/journals/lanre…

Asthma & COPD breakthrough! For 1st time in 50 yrs, a new treatment's been found. Dr Sanjay Ramakrishnan's (Sanjay Ramakrishnan) trial shows benralizumab injection reduces severe asthma & COPD attacks. resphealth.org.au/2024/11/new-ho… #AsthmaTreatment #COPD #RespiratoryHealth

Biologics for exacerbations, game-changer!

Breaking News! 🎉 A major breakthrough in asthma treatment! 🫁 A trial managed by Oxford Respiratory Trials has discovered the first new treatment for asthma attacks in 50 years. This could revolutionize care for millions. University of Oxford Nuffield Department of Medicine #research bbc.co.uk/news/articles/…

Woohooo! Thank you for showcasing our work The Lancet Respiratory Medicine

Such an important study. In people with acute asthma and COPD with eosinophilia regimes containing benralizumab were superior to prednisone alone in reference treatment failure at 90 days

Here’s the study that’s been making the headlines. Congratulations to all the team for delivering this challenging study. Exciting times ahead… 👀 ⬇️

ABRA kadabra 🪄.. possibly a new drug for COPD 🤞🏾

💉For the first time in 50 years there is a new treatment that helps improve the management of asthma and chronic obstructive pulmonary disease attacks! UWA Research Respiratory Health Sanjay Ramakrishnan uwa.au/awq4bm